tm logo

Monitor this mark

View On USPTO

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 05 Aug 2020

Last Applicant/ Owned by

Enteris BioPharma, Inc.

83 Fulton Street

Boonton

NJ

07005

Serial Number

86027541 filed on 02th Aug 2013

Registration Number

4585894 registered on 12th Aug 2014

in the Principal Register

Correspondent Address

David J. Dykeman

David J. Dykeman

Suite 2000

One International Place

Boston MA 02110

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY

Research and development of oral drug formulations and pharmaceuticals

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Research and development of oral drug formulations and pharmaceuticals

First Use Date in General

06th Feb 2014

First Use Date in Commerce

06th Feb 2014

Mark Details

Serial Number

No 86027541

Mark Type

No Service Mark

Attorney Docket Number

No 146551-03090

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
12th Aug 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05th Aug 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Aug 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05th Aug 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
18th May 2020TEAS SECTION 8 & 15 RECEIVED
12th Aug 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18th Jul 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18th Jul 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12th Aug 2014REGISTERED-PRINCIPAL REGISTER
11th Jul 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED